Mei Ying Zhu
Technik-/Wissenschafts-/F&E-Leiter bei WUXI XDC CAYMAN INC.
Profil
Mei Ying Zhu is currently the Chief Technology Officer at WuXi XDC Cayman, Inc. She previously worked as the Chief Executive Officer at MabPlex USA, Inc., Associate Director at Xencor, Inc., Senior Director-Process Sciences & Manufacturing at Astellas Pharma, Inc., and Manager-Bioprocess Development at Bristol-Myers Squibb International Corp.
She also served as the Chief Technology Officer at RemeGen Co., Ltd.
from 2019 to 2023.
Zhu holds a graduate degree from the Illinois Institute of Technology, an undergraduate degree from Tsinghua University, and a doctorate from the University of Wisconsin Business School.
Aktive Positionen von Mei Ying Zhu
| Unternehmen | Position | Beginn |
|---|---|---|
| WUXI XDC CAYMAN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2023 |
Ehemalige bekannte Positionen von Mei Ying Zhu
| Unternehmen | Position | Ende |
|---|---|---|
| REMEGEN CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2023 |
| Bristol-Myers Squibb International Corp. | Corporate Officer/Principal | - |
| XENCOR, INC. | Private-Equity-Analyst | - |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
MabPlex USA, Inc.
 MabPlex USA, Inc. BiotechnologyHealth Technology MabPlex USA, Inc. is a biopharmaceutical contract manufacturer that specializes in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. The American company offers a range of services including regulatory services, medium manufacturing, CMC strategy, management, and communication. MabPlex provides end-to-end CMO services such as cell banking, protein-related drug DS/DP manufacturing, ADC DS/DP manufacturing, and product testing. The private company is an industry-leading company that provides CDMO services for biologics, with a focus on antibody drug conjugates, research, development, manufacturing, and regulatory services. | Vorstandsvorsitzender | - |
Ausbildung von Mei Ying Zhu
| Tsinghua University | Undergraduate Degree |
| Illinois Institute of Technology | Graduate Degree |
| University of Wisconsin Business School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| WUXI XDC CAYMAN INC. | Commercial Services |
| REMEGEN CO., LTD. | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
MabPlex USA, Inc.
MabPlex USA, Inc. BiotechnologyHealth Technology MabPlex USA, Inc. is a biopharmaceutical contract manufacturer that specializes in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. The American company offers a range of services including regulatory services, medium manufacturing, CMC strategy, management, and communication. MabPlex provides end-to-end CMO services such as cell banking, protein-related drug DS/DP manufacturing, ADC DS/DP manufacturing, and product testing. The private company is an industry-leading company that provides CDMO services for biologics, with a focus on antibody drug conjugates, research, development, manufacturing, and regulatory services. | Health Technology |
| Bristol-Myers Squibb International Corp. |
